Levo-Dromoran

Levo-Dromoran Brand names, Levo-Dromoran Analogs

Levo-Dromoran Brand Names Mixture

No information avaliable

Levo-Dromoran Chemical_Formula

C₁₇H₂₃NO

Levo-Dromoran RX_link

http://www.rxlist.com/cgi/generic2/levorphanol.htm

Levo-Dromoran fda sheet

Levo-Dromoran msds (material safety sheet)

Levo-Dromoran MSDS

Levo-Dromoran Synthesis Reference

Woods LA, et al. J Pharmacol Exp Ther. 1958 Sep;124(1):1-8.

Levo-Dromoran Molecular Weight

257.371 g/mol

Levo-Dromoran Melting Point

198-199 ^oC

Levo-Dromoran H₂O Solubility

1840 mg/L

Levo-Dromoran State

Solid

Levo-Dromoran LogP

3.986

Levo-Dromoran Dosage Forms

Tablet

Levo-Dromoran Indication

For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate

Levo-Dromoran Pharmacology

Levorphanol is a potent synthetic opioid analgesic indicated for the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate. Levorphanol is similar to morphine in its actions, however it is up to 8 times more potent than morphine. Levorphanol produces a degree of respiratory depression similar to that produced by morphine at equianalgesic doses, and like many mu-opioid drugs, levorphanol produces euphoria or has a positive effect on mood in many individuals.

Levo-Dromoran Absorption

Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.

Levo-Dromoran side effects and Toxicity

LD₅₀=150 mg/kg (orally in rats). Signs of overdose include nausea, emesis, dizziness, respiratory depression, hypotension, urinary retention, cardiac arrhythmias, allergic reactions, skin rash, and uticaria.

Levo-Dromoran Patient Information

No information avaliable

Levo-Dromoran Organisms Affected

Humans and other mammals